CDIO
Price
$4.16
Change
+$0.10 (+2.46%)
Updated
Sep 26, 02:50 PM (EDT)
Capitalization
7.16M
LIANY
Price
$0.06
Change
-$0.01 (-14.29%)
Updated
Sep 25 closing price
Capitalization
6.11M
46 days until earnings call
Interact to see
Advertisement

CDIO vs LIANY

Header iconCDIO vs LIANY Comparison
Open Charts CDIO vs LIANYBanner chart's image
Cardio Diagnostics Holdings
Price$4.16
Change+$0.10 (+2.46%)
Volume$500
Capitalization7.16M
LianBio
Price$0.06
Change-$0.01 (-14.29%)
Volume$9.06K
Capitalization6.11M
CDIO vs LIANY Comparison Chart in %
Loading...
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CDIO vs. LIANY commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CDIO is a StrongBuy and LIANY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (CDIO: $4.06 vs. LIANY: $0.06)
Brand notoriety: CDIO and LIANY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CDIO: 121% vs. LIANY: 8%
Market capitalization -- CDIO: $7.16M vs. LIANY: $6.11M
CDIO [@Biotechnology] is valued at $7.16M. LIANY’s [@Biotechnology] market capitalization is $6.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CDIO’s FA Score shows that 0 FA rating(s) are green whileLIANY’s FA Score has 1 green FA rating(s).

  • CDIO’s FA Score: 0 green, 5 red.
  • LIANY’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than CDIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CDIO’s TA Score shows that 6 TA indicator(s) are bullish while LIANY’s TA Score has 4 bullish TA indicator(s).

  • CDIO’s TA Score: 6 bullish, 3 bearish.
  • LIANY’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, CDIO is a better buy in the short-term than LIANY.

Price Growth

CDIO (@Biotechnology) experienced а +4.91% price change this week, while LIANY (@Biotechnology) price change was +3.13% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.17%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +55.19%.

Reported Earning Dates

LIANY is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+4.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CDIO($7.16M) has a higher market cap than LIANY($6.11M). LIANY YTD gains are higher at: -78.868 vs. CDIO (-85.242). CDIO has less debt than LIANY: CDIO (546K) vs LIANY (2.84M).
CDIOLIANYCDIO / LIANY
Capitalization7.16M6.11M117%
EBITDA-5.85MN/A-
Gain YTD-85.242-78.868108%
P/E RatioN/AN/A-
Revenue19.5KN/A-
Total Cash7.97MN/A-
Total Debt546K2.84M19%
TECHNICAL ANALYSIS
Technical Analysis
CDIOLIANY
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
48%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
79%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
61%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
29%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CDIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LIANY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MURA2.09N/A
N/A
Mural Oncology plc
LMT484.34-1.91
-0.39%
Lockheed Martin Corp
KYTX6.35-0.09
-1.40%
Kyverna Therapeutics
AMPH26.36-0.51
-1.90%
Amphastar Pharmaceuticals
AXSM116.01-2.76
-2.32%
Axsome Therapeutics

CDIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CDIO has been loosely correlated with NEVPF. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if CDIO jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CDIO
1D Price
Change %
CDIO100%
-4.92%
NEVPF - CDIO
43%
Loosely correlated
N/A
KRRO - CDIO
35%
Loosely correlated
-0.99%
PLX - CDIO
30%
Poorly correlated
-0.97%
TARA - CDIO
30%
Poorly correlated
+5.15%
LIANY - CDIO
28%
Poorly correlated
-15.43%
More

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with KRRO. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then KRRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
-15.43%
KRRO - LIANY
67%
Closely correlated
-0.99%
AVTX - LIANY
39%
Loosely correlated
-0.43%
IBIO - LIANY
37%
Loosely correlated
-3.64%
MTNB - LIANY
34%
Loosely correlated
-2.08%
LIXT - LIANY
34%
Loosely correlated
-1.69%
More